[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Anna Huguenard\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":40},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":5},"100405303",false,"NCT04557618","Auricular VNS Following Subarachnoid Hemorrhage","Transcutaneous Auricular Vagus Nerve Stimulation Following Spontaneous Subarachnoid Hemorrhage","Inclusion Criteria:\n\n* Spontaneous subarachnoid hemorrhage\n\nExclusion Criteria:\n\n* Trauma-induced subarachnoid hemorrhage\n* Ongoing chemotherapy\n* Taking immunosuppressive medications for other medical illnesses\n* Presence of a pacemaker\n* Prolonged bradycardia at time of admission","ALL","18 Years",{"count":18,"type":19},50,"ESTIMATED","INTERVENTIONAL",[22],"NA","This study will evaluate whether non-invasive auricular vagal nerve stimulation lowers inflammatory markers, and improves outcomes following spontaneous subarachnoid hemorrhage.",[25],"Subarachnoid Hemorrhage",[27],"Vagal nerve stimulation","RECRUITING","2025-12-18",{"date":31,"type":32},"2025-12-26","ACTUAL",{"date":34,"type":32},"2021-01-05",{"date":36,"type":19},"2028-12",{"name":38,"class":39},"Anna Huguenard","OTHER",""]